Global Radiosurgery Systems (Neurology Devices) Market – Industry Trends and Forecast to 2030

Global Radiosurgery Systems (Neurology Devices) Market, By Device Type (CSF Management Devices, CSF Shunt Devices, CSF Drainage Devices, Interventional Neurology Devices), Neuro-Surgery Devices (Neuro-endoscopes, Stereotactic- Systems, Ultrasonic- Aspirators, Aneurysm Clips), Neuro-stimulation Devices (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Nerve Stimulation), End User (Hospitals, Neurology Clinics, Ambulatory Care Centers, and Others) – Industry Trends and Forecast to 2030.

Radiosurgery Systems (Neurology Devices) Market Analysis and Size

Major factors that are expected to boost the growth of the radiosurgery systems (Neurology Devices) market in the forecast period are the growing of the prevalence of neurological disorders, large investments by the private players in the neurology devices and the rise in the research and development in the field of neurotherapy and growing of the elderly population. Furthermore, the growing of prevalence of neurological disorders that incorporate brain aneurysms, brain tumours, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke is further anticipated to propel the growth of the radiosurgery systems (Neurology Devices) market. On the other hand, the increase in the price of radiosurgery systems is further responsible to impede the growth of the radiosurgery systems (Neurology Devices) market in the near future.

Data Bridge Market Research analyses that the global radiosurgery systems (neurology devices) market was USD 1,798.68 million in 2022, is expected to reach USD 2,722.19 million by 2030, and is expected to undergo a CAGR of 5.11% during the forecast period of 2023 to 2030. “CSF management devices”  dominates the device type segment of the global radiosurgery systems (neurology devices) market owing to the advancements in technology that have led to the development of various product in flied of radiology . In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Radiosurgery Systems (Neurology Devices) Market Scope and Segmentation

Market Definition

Radiosurgery systems (neurology devices) refers to the market for medical devices used in the field of neurology for the treatment of various neurological conditions through radiosurgery techniques. Radiosurgery is a non-invasive surgical procedure that uses highly focused radiation beams to target and treat specific areas of the brain or nervous system.

Global Radiosurgery Systems (Neurology Devices) Market Dynamics

Drivers

• Growing Demand for Non-Invasive Treatments

Radiosurgery systems offer non-invasive treatment options for various neurological conditions, including brain tumors, arteriovenous malformations (AVMs), trigeminal neuralgia, and essential tremors. As patients seek alternatives to traditional surgery, the demand for radiosurgery systems has increased.

• Rising Prevalence of Neurological Disorders

The prevalence of neurological disorders, such as brain tumors and movement disorders, is increasing globally. Radiosurgery systems provide a targeted and precise treatment option for these conditions, driving the demand for these devices.

• Increasing Awareness and Education

With advancements in medical education and awareness campaigns, both healthcare providers and patients are becoming more knowledgeable about the benefits of radiosurgery systems. This increased awareness has contributed to the growing adoption of these devices.

Opportunities

• Technological Advancements to Cure Disease in a Better Way

Technological advancements have greatly improved the precision, accuracy, and safety of radiosurgery systems. The development of image-guided systems, real-time imaging, and robotic-assisted platforms has made radiosurgery more effective and minimally invasive, leading to increased adoption.

• Cost-Effectiveness of New Devices

Radiosurgery systems can be cost-effective compared to traditional surgical procedures. They often result in shorter hospital stays, reduced post-operative complications, and faster recovery times. These factors make radiosurgery systems an attractive option for both hospitals and patients.

Restraints/Challenges

• High Cost to Acquire and Maintain

Radiosurgery systems can be expensive to acquire and maintain. The initial investment, along with ongoing maintenance costs, can be a significant barrier for healthcare providers, especially those with limited financial resources. The high cost of these systems can limit their accessibility and adoption.

• Limited Access and Infrastructure

Radiosurgery systems require specialized infrastructure and expertise for their operation. Not all healthcare facilities may have the necessary resources, such as trained personnel, dedicated treatment rooms, or advanced imaging capabilities, to effectively utilize these systems. Limited access to specialized centers can restrict the availability of radiosurgery treatments. Workplace monitoring and measurement equipment.

This segment includes the development and sale of monitoring and measurement equipment that assesses air quality, particulate matter levels, and exposure to harmful substances. Innovations in real-time monitoring are driving growth in this area.

• Regulatory Compliance Solutions

Companies often invest in software and solutions that help them navigate and comply with occupational health and safety regulations related to respiratory hazards. These solutions assist in managing compliance records and safety data.

This global radiosurgery systems (neurology devices) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global radiosurgery systems (neurology devices) market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In February 2021, Accuray Inc., received FDA clearance for its ClearRT Helical kVCT imaging for the Radixact System
• In November 2020, Varian received FDA clearance for its Ethos therapy, an adaptive intelligence solution that combines treatment delivery with real-time imaging and personalized adaptive therapy

Global Radiosurgery Systems (Neurology Devices) Market Scope

The global radiosurgery systems (neurology devices) market is segmented on the basis of device type, interventional neurology devices, neuro-surgery devices, neuro-stimulation devices and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

• CSF Management devices
• CSF Shunt Devices
• CSF Drainage Devices
• Interventional Neurology Devices
• Neuro Thromobectomy
• Cerebral Balloon Angioplasty
• Stents, Aneurysm Coiling
• Support Devices

Neuro-Surgery Devices

• Neuro-endoscopes
• Stereotactic- Systems
• Ultrasonic- Aspirators
• Aneurysm Clips

Neuro-Stimulation Devices

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Gastric Nerve Stimulation

End User

• Hospitals
• Neurology Clinics
• Ambulatory Care Centers
• Others

Global Radiosurgery Systems (Neurology Devices) Market Regional Analysis/Insights

The global radiosurgery systems (neurology devices) market is analysed and market size insights and trends are provided by country, device type, interventional neurology devices, neuro-surgery devices, neuro-stimulation devices and end user as referenced above.

The countries covered in the global radiosurgery systems (neurology devices) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global radiosurgery systems (neurology devices) market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the global radiosurgery systems (neurology devices) market and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth in the global radiosurgery systems (neurology devices) market during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global radiosurgery systems (neurology devices) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global radiosurgery systems (neurology devices) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global radiosurgery systems (neurology devices) market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Radiosurgery Systems (Neurology Devices) Market Share Analysis

The global radiosurgery systems (neurology devices) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global radiosurgery systems (neurology devices) market.

Some of the major players operating in the global radiosurgery systems (neurology devices) market are:

•  Abbott (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• Stryker Corporation (U.S.)
• Medtronic (Ireland)
• Terumo Corporation (Japan)
• Penumbra, Inc. (U.S.)
• MicroPort Scientific Corporation (China)
• Merit Medical Systems - (U.S.)
• W.L. Gore & Associates, Inc. - (U.S.)
• B. Braun Melsungen AG (Germany)
• Cook  (U.S.)
• UreSil, LLC  (U.S.)
• Medikit co., ltd. (Japan)
• Bayer AG (Germany)
• Acandis GmbH (Germany)
• Biosensors International Group, Ltd.  (Singapore)
• Integra LifeSciences Corporation (U.S.)
• Elekta (Sweden)
• C.R. Bard, Inc. (U.S.)